| Sep 3 |
Aspire Biopharma and PowerUp Acquisition announce business combination agreement
|
| Sep 3 |
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
|
| Jul 31 |
Powerup Acquisition signs letter of intent for a potential merger with Aspire Biopharma
|
| Jul 31 |
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
|
| Jun 5 |
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
|
